IRADIMED CORPORATION Debt Securities, Available-for-sale, Realized Gain (Loss)
IRADIMED CORPORATION (IRMD) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $8.03 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-01.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2024-03-01
- IRADIMED CORPORATION debt securities, available-for-sale, realized gain (loss) for the quarter ending 2022-12-31 was $0.00.
- IRADIMED CORPORATION debt securities, available-for-sale, realized gain (loss) for the quarter ending 2022-09-30 was $0.00.
- IRADIMED CORPORATION debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $8.03K, a 56.84% decline from fiscal 2021.
- IRADIMED CORPORATION debt securities, available-for-sale, realized gain (loss) for fiscal 2021 was $18.59K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $8.03K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $8.03K 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $8.03K 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $18.59K 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |